Merck (MEX:MRK) Valuation Rank


MEX:MRK Merck & Co Inc MEX:MRK
74 GF Score
Price MXN2,240.00
GF Value MXN2,048.95
Valuation Fairly Valued
! 7 Warning Signs
View Full Analysis

What is Merck Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Merck Valuation Rank Related Terms

MEX:MRK
74GF Score
Merck & Co Inc MEX:MRK
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Merck (MEX:MRK) Overvalued in 2026?

Based on GuruFocus' analysis, Merck stock appears to be overvalued. The current stock price of MXN2,240.00 is trading 9.3% above its estimated GF Value™ of MXN2,048.95. GuruFocus considers Merck to be Fairly Valued.

Key valuation signals for MEX:MRK:

  • Valuation Rank:
  • GF Value™: MXN2,048.95 vs. price of MXN2,240.00 (9.3% above fair value)
  • GF Score™: 74/100 with 7 warning signs

No single metric tells the full story. See the MEX:MRK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Merck Business Description

Address 126 East Lincoln Avenue, Rahway, NJ, USA, 07065
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).
74GF Score

Get the complete analysis for MEX:MRK

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN2,240.00
Price
MXN2,048.95
GF Value